D
Atai Life Sciences N.V. ATAI
$4.76 -$0.07-1.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 51.62% 1.06% -112.98% -159.41% -73.45%
Total Depreciation and Amortization 176.83% 160.24% 122.77% 12.16% 3.80%
Total Amortization of Deferred Charges -72.45% 52.04% 89.90% 32.32% 7.69%
Total Other Non-Cash Items -85.32% 10.93% 381.01% 115.45% 303.31%
Change in Net Operating Assets 170.76% 65.52% -253.01% -988.86% 246.57%
Cash from Operations 13.15% 20.96% -10.62% -4.94% 28.24%
Capital Expenditure -- -- 25.00% -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -25.21% -- --
Divestitures -- -- -- -- --
Other Investing Activities -39.20% -187.14% 828.52% 153.99% 173.98%
Cash from Investing -39.98% -196.02% 897.08% 153.44% 174.08%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 5,919.02% -- 710.53% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 100.00% -- --
Cash from Financing 2,279.45% -- 101.82% -- 426.00%
Foreign Exchange rate Adjustments 212.12% 150.00% 158.02% -25.47% 186.84%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 683.91% 375.65% 44.50% 116.46% 101.04%